Fetal exposure to mercury and lead from intrauterine blood transfusions

Alison J. Falck, Sripriya Sundararajan, Faeq Al-Mudares, Stephen A. Contag, Cynthia F. Bearer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background: Mercury (Hg) and lead (Pb) exposure during childhood is associated with irreversible neurodevelopmental effects. Fetal exposure to Hg and Pb from intrauterine blood transfusion (IUBT) has not been reported. Methods: Fetal exposure was estimated based on transfusion volume and metal concentration in donor packed red blood cell (PRBCs). As biomarkers to quantify prenatal exposure are unknown, Hg and Pb in donor PRBCs were compared to estimated intravenous (IV) RfDs based on gastrointestinal absorption. Results: Three pregnant women received 8 single-donor IUBTs with volumes ranging from 19 to 120 mL/kg. Hg and Pb were present in all donor PRBC units. In all, 1/8 IUBT resulted in Hg dose five times higher than the estimated IV RfD. Median Pb dose in one fetus who received 5 single-donor IUBTs between 20–32 weeks gestation was 3.4 μg/kg (range 0.5–7.9 μg/kg). One donor unit contained 12.9 μg/dL of Pb, resulting in a fetal dose of 7.9 μg/kg, 40 times higher than the estimated IV RfD at 20 weeks gestation. Conclusion: This is the first study documenting inadvertent exposure to Hg and Pb from IUBT and quantifying the magnitude of exposure. Screening of donor blood is warranted to prevent toxic effects from Hg and Pb to the developing fetus.

Original languageEnglish (US)
Pages (from-to)510-514
Number of pages5
JournalPediatric Research
Volume86
Issue number4
DOIs
StatePublished - Oct 1 2019

PubMed: MeSH publication types

  • Journal Article

Fingerprint Dive into the research topics of 'Fetal exposure to mercury and lead from intrauterine blood transfusions'. Together they form a unique fingerprint.

Cite this